Astellas to take over Caduet distribution in Japan
This article was originally published in Scrip
Executive Summary
Pfizer will transfer Japanese distribution rights to the fixed-dose combination product Caduet (amlodipine besylate plus atorvastatin) to its local co-promotion partner Astellas on 1 October.